Please login to the form below

Not currently logged in

Pharmaceutical Market Europe (PME)

PME is a monthly print and digital title written by experienced journalists and high-profile pharma and healthcare experts. The magazine provides insights and offers solutions to the issues that keep industry leaders awake at night.

From the latest developments in cancer treatments and the strategies behind them to new marketing and commercialisation models and the regulations that underpin the fabric of the sector – PME's got it covered.

PME is a trusted source for decision makers and influencers in pharma and healthcare who, through the practical and accessible content, have the knowledge to tackle whatever comes their way.

From: Regulatory

Celgene’s Revlimid scores NICE approval in follicular lymphoma

NICE (National for Health and Clinical Excellence)New ‘chemotherapy-free’ treatment for patients with limited options

From: Regulatory

Lilly’s Cyramza narrowly clears FDA adcomm vote for first-line NSCLC

Eli Lilly new HQAdvisory committee voted 6-5 in favour of drug

From: Research

Menlo slumps as itching drug fails mid-stage trial

Menlo TherapeuticsShares in US biotech closed down almost a third after announcement

From: Research

Trial of Amgen, Servier’s heart failure drug clears interim check

Amgen flagDrug could become a $2bn product if approved


Pharmaceutical Market Europe - February 2020

Pharmaceutical Market Europe (PME) magazine is also available on the iPhone/iPad as a free app

Editor - Iona Everson

Have your say...

Ex-BMS exec jumps to Gilead to lead research group

Gilead appoints Michael Quigley to lead research team

Mike Quigley

'Nothing about us without us'

Why patient engagement is essential throughout the entire product life cycle

Meike Wenzel

Policy and public health: all the decisions we can't see

January was a bad month for healthcare in China

Coronavirus figures

Featured jobs

Subscribe to our email news alerts


Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

The ALS patient journey
Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the...
Equipping your medical affairs teams with solutions to navigate the healthcare landscape
Dr Tyler Ray, OPEN Health Medical Communications...
Protein degraders
Can protein degraders unlock ‘undruggable’ drug targets?
Exploring a new and exciting area of small-molecule drug discovery...